Pulmonary disease among inpatient decedents: Impact of schizophrenia

Laurel A. Copeland, Eric M. Mortensen, John E. Zeber, Mary Jo Pugh, Marcos Restrepo, Gregory W. Dalack

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Objectives: Determine the risk associated with schizophrenia for common pulmonary illness (pneumonia and chronic obstructive pulmonary disorder (COPD)) during the last year of life. Methods: Inpatient decedents in Veterans (VA) hospitals in 2002 (N = 27,798) were identified. Logistic regression modeled diagnosis of pulmonary illness in either the final year or final admission as a function of schizophrenia, smoking history and other covariates. Results: Among decedents, 943 (3%) had schizophrenia, 3% were women, most were white (76%) or African-American (18%), and average age at death was 72.4 years (SD 11.5). Three-fifths received VA outpatient care in the year prior to death. Among those with schizophrenia, only two-fifths had outpatient care. Pneumonia was more common among schizophrenia patients (38% vs 31%) as was COPD (46% vs 38%). In models controlling for history of smoking and other covariates, schizophrenia was a risk factor for pulmonary disease in the last year of life (OR = 1.9, 95% CI 1.6-2.2) but less so for final-stay pulmonary disease (OR = 1.5, 95% CI 1.3-1.7). Conclusions: VA inpatient decedents with schizophrenia were at increased risk for pneumonia and COPD, independent of smoking indicators. Clinicians treating schizophrenia patients need to be especially alert to potential comorbid medical conditions and ensure vulnerable patients receive appropriate care.

Original languageEnglish (US)
Pages (from-to)720-726
Number of pages7
JournalProgress in Neuro-Psychopharmacology and Biological Psychiatry
Volume31
Issue number3
DOIs
StatePublished - Apr 30 2007

Fingerprint

Lung Diseases
Inpatients
Schizophrenia
Lung
Pneumonia
Smoking
Veterans
Ambulatory Care
Veterans Hospitals
African Americans
Chronic Disease
Logistic Models
History

Keywords

  • Health Services
  • Mortality
  • Respiratory Disorders
  • Schizophrenia
  • Veterans

ASJC Scopus subject areas

  • Biological Psychiatry
  • Pharmacology

Cite this

Pulmonary disease among inpatient decedents : Impact of schizophrenia. / Copeland, Laurel A.; Mortensen, Eric M.; Zeber, John E.; Pugh, Mary Jo; Restrepo, Marcos; Dalack, Gregory W.

In: Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 31, No. 3, 30.04.2007, p. 720-726.

Research output: Contribution to journalArticle

Copeland, Laurel A. ; Mortensen, Eric M. ; Zeber, John E. ; Pugh, Mary Jo ; Restrepo, Marcos ; Dalack, Gregory W. / Pulmonary disease among inpatient decedents : Impact of schizophrenia. In: Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2007 ; Vol. 31, No. 3. pp. 720-726.
@article{d55275f768f24649874a40da64ca877c,
title = "Pulmonary disease among inpatient decedents: Impact of schizophrenia",
abstract = "Objectives: Determine the risk associated with schizophrenia for common pulmonary illness (pneumonia and chronic obstructive pulmonary disorder (COPD)) during the last year of life. Methods: Inpatient decedents in Veterans (VA) hospitals in 2002 (N = 27,798) were identified. Logistic regression modeled diagnosis of pulmonary illness in either the final year or final admission as a function of schizophrenia, smoking history and other covariates. Results: Among decedents, 943 (3{\%}) had schizophrenia, 3{\%} were women, most were white (76{\%}) or African-American (18{\%}), and average age at death was 72.4 years (SD 11.5). Three-fifths received VA outpatient care in the year prior to death. Among those with schizophrenia, only two-fifths had outpatient care. Pneumonia was more common among schizophrenia patients (38{\%} vs 31{\%}) as was COPD (46{\%} vs 38{\%}). In models controlling for history of smoking and other covariates, schizophrenia was a risk factor for pulmonary disease in the last year of life (OR = 1.9, 95{\%} CI 1.6-2.2) but less so for final-stay pulmonary disease (OR = 1.5, 95{\%} CI 1.3-1.7). Conclusions: VA inpatient decedents with schizophrenia were at increased risk for pneumonia and COPD, independent of smoking indicators. Clinicians treating schizophrenia patients need to be especially alert to potential comorbid medical conditions and ensure vulnerable patients receive appropriate care.",
keywords = "Health Services, Mortality, Respiratory Disorders, Schizophrenia, Veterans",
author = "Copeland, {Laurel A.} and Mortensen, {Eric M.} and Zeber, {John E.} and Pugh, {Mary Jo} and Marcos Restrepo and Dalack, {Gregory W.}",
year = "2007",
month = "4",
day = "30",
doi = "10.1016/j.pnpbp.2007.01.008",
language = "English (US)",
volume = "31",
pages = "720--726",
journal = "Progress in Neuro-Psychopharmacology and Biological Psychiatry",
issn = "0278-5846",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Pulmonary disease among inpatient decedents

T2 - Impact of schizophrenia

AU - Copeland, Laurel A.

AU - Mortensen, Eric M.

AU - Zeber, John E.

AU - Pugh, Mary Jo

AU - Restrepo, Marcos

AU - Dalack, Gregory W.

PY - 2007/4/30

Y1 - 2007/4/30

N2 - Objectives: Determine the risk associated with schizophrenia for common pulmonary illness (pneumonia and chronic obstructive pulmonary disorder (COPD)) during the last year of life. Methods: Inpatient decedents in Veterans (VA) hospitals in 2002 (N = 27,798) were identified. Logistic regression modeled diagnosis of pulmonary illness in either the final year or final admission as a function of schizophrenia, smoking history and other covariates. Results: Among decedents, 943 (3%) had schizophrenia, 3% were women, most were white (76%) or African-American (18%), and average age at death was 72.4 years (SD 11.5). Three-fifths received VA outpatient care in the year prior to death. Among those with schizophrenia, only two-fifths had outpatient care. Pneumonia was more common among schizophrenia patients (38% vs 31%) as was COPD (46% vs 38%). In models controlling for history of smoking and other covariates, schizophrenia was a risk factor for pulmonary disease in the last year of life (OR = 1.9, 95% CI 1.6-2.2) but less so for final-stay pulmonary disease (OR = 1.5, 95% CI 1.3-1.7). Conclusions: VA inpatient decedents with schizophrenia were at increased risk for pneumonia and COPD, independent of smoking indicators. Clinicians treating schizophrenia patients need to be especially alert to potential comorbid medical conditions and ensure vulnerable patients receive appropriate care.

AB - Objectives: Determine the risk associated with schizophrenia for common pulmonary illness (pneumonia and chronic obstructive pulmonary disorder (COPD)) during the last year of life. Methods: Inpatient decedents in Veterans (VA) hospitals in 2002 (N = 27,798) were identified. Logistic regression modeled diagnosis of pulmonary illness in either the final year or final admission as a function of schizophrenia, smoking history and other covariates. Results: Among decedents, 943 (3%) had schizophrenia, 3% were women, most were white (76%) or African-American (18%), and average age at death was 72.4 years (SD 11.5). Three-fifths received VA outpatient care in the year prior to death. Among those with schizophrenia, only two-fifths had outpatient care. Pneumonia was more common among schizophrenia patients (38% vs 31%) as was COPD (46% vs 38%). In models controlling for history of smoking and other covariates, schizophrenia was a risk factor for pulmonary disease in the last year of life (OR = 1.9, 95% CI 1.6-2.2) but less so for final-stay pulmonary disease (OR = 1.5, 95% CI 1.3-1.7). Conclusions: VA inpatient decedents with schizophrenia were at increased risk for pneumonia and COPD, independent of smoking indicators. Clinicians treating schizophrenia patients need to be especially alert to potential comorbid medical conditions and ensure vulnerable patients receive appropriate care.

KW - Health Services

KW - Mortality

KW - Respiratory Disorders

KW - Schizophrenia

KW - Veterans

UR - http://www.scopus.com/inward/record.url?scp=33947547127&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947547127&partnerID=8YFLogxK

U2 - 10.1016/j.pnpbp.2007.01.008

DO - 10.1016/j.pnpbp.2007.01.008

M3 - Article

C2 - 17292522

AN - SCOPUS:33947547127

VL - 31

SP - 720

EP - 726

JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry

JF - Progress in Neuro-Psychopharmacology and Biological Psychiatry

SN - 0278-5846

IS - 3

ER -